ZFX promotes laryngeal squamous cell carcinoma, hepatocellular carcinoma, gastric cancer, bladder cancer, and pancreatic cancer and is associated with poor patient prognosis [47–51]. The gene discussed is ZFX; the disease is laryngeal squamous cell carcinoma.